Second Opinion October 8, 2025
Anjalee Khemlani

We could be entering a future where we may see far fewer television ads featuring prescription pharmaceuticals. Consumers might applaud that, but as a longtime health and biotech industry journalist, I don’t think we’re talking nearly enough about the potential impact. It doesn’t just matter for pharma, but also for digital health companies that are starting to follow the playbook – and may be deterred from pursuing TV and streaming ads further.

“The administration’s recent actions have certainly created a moment of pause for the industry. Pharma companies are...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, Digital Health, FDA, Govt Agencies, Pharma, Pharma / Biotech, Technology
The Medical Futurist’s 100 Digital Health And AI Companies Of 2026
The $20B Opportunity: Transforming Unused Health Data into a Strategic Asset
ICT&health World Conference: meeting and sharing information
‘It really does take a village to innovate in healthcare’
Canada: Acute Care EHR & Digital Health 2026-What's Changing Now in Adoption, Implementation, Selection and Satisfaction - Black Book Research

Share Article